Been looking into healthcare ETF options lately and figured I'd share what I found. There are actually some solid pharma-focused funds out there if you want exposure to the sector without picking individual stocks. The main appeal is pretty straightforward - you get diversification across multiple pharma companies, which means less volatility than holding a single stock even if one of them has a rough quarter.

I pulled together the top 5 by assets under management. VanEck's PPH is the biggest with around 1.2 billion, tracking 26 pharma companies including the usual suspects like Eli Lilly, Merck, and Novo Nordisk. The expense ratio is reasonable at 0.36 percent. Then there's iShares' IHE with 959 million in assets - it's got 45 holdings and is pretty heavy on Johnson & Johnson and Eli Lilly (like 45 percent of the portfolio combined). If you want broader exposure, Invesco's PJP healthcare ETF has 31 companies and came out back in 2005.

State Street's XPH is interesting because it weights its 52 holdings pretty evenly instead of concentrating on the mega-caps. And if you're looking at international exposure, KraneShares has a China healthcare ETF tracking 50 Chinese biotech and pharma stocks. All of these have expense ratios under 0.7 percent, which is pretty standard for sector-specific healthcare ETF products.

Obviously these aren't recommendations - just what's available if you want to get into pharma without individual stock picking. The expense ratios and holdings vary, so worth checking which one matches your strategy.